We found a new enzyme that efficiently catalyzes transglycosylation reaction toward phenolic hydroxyl groups. The enzyme, hydroquinone glucosylating enzyme, catalyzed α-anomer selective glycosylation of hydroquinone, and the yield of the resulting product, 4-hydroxyphenyl-O-α-Dglucopyranoside, was high enough to be used for industrial production. Kojic acid, caffeic acid, and many other phenolic compounds were also glycosylated by the reaction of this enzyme. However, alcohols were not glycosylated by the enzyme. The application studies of 4-hydroxyphenyl-O-α-Dglucopyranoside, i.e., α-arbutin were carried out. α-Arbutin strongly inhibited human tyrosinase, and its inhibitory effect on human tyrosinase was much higher than that of its isomer, 4-hydroxyphenyl-O-β-D-glucopyranoside, i.e., arbutin. We also synthesized some kinds of glycosides of α-arbutin and arbutin. The comparison of their inhibitory effects on human tyrosinase indicated that the molecular size and electrostatic potentials around the benzene ring are important for inducing the inhibitory effect of hydroquinone glycosides toward human tyrosinase. We examined the inhibitory effects of α-arbutin on melanin biosynthesis. α-Arbutin inhibited melanin syntheses of HMV-II cells and human skin model in a dose-dependent manner at noncytotoxic concentrations. These results demonstrate that α-arbutin is an effective and safe ingredient for skin-lightening.
be used to make water-insoluble compounds water-soluble, and improves pharmacological properties, as in the case of salicylic acid. However, there had been few reports on the glycosylation of phenolic compounds by microbial enzymes. Thus, we screened soil microorganisms for the production of hydroquinone glucosylating enzyme as a model of the enzyme that can catalyze the glycosylation of phenolic compounds effectively. In this review, we describe in detail the isolation and the characterization of a hydroquinone glucosylating enzyme and application studies of α-arbutin, hydroquinone-αglucoside, for a cosmetic ingredient.
B. Isolation of Hydroquinone Glucosylating Enzyme
We succeeded in isolating a strain of Bacillus subtilis which produced hydroquinone glucosylating enzyme from approximately 600 strains isolated from soil (1) . The enzyme was purified and its properties characterized. The molecular mass of the enzyme was estimated as 65 kDa by SDS-PAGE, and 54 kDa by gel filtration. Based on an analysis of the hydrolytic products from soluble starch, the enzyme was categorized in α-amylase, and its pattern on soluble starch is very similar to that of bacterial saccharifying α-amylase (2) . Thus some of the properties of the enzyme were compared with those of bacterial saccharifying α-amylase. The enzyme was found to be more stable and active than bacterial saccharifying α-amylase both at high temperatures and under strongly alkaline conditions. These results suggest that the enzyme possesses certain properties which are clearly different from those of bacterial saccharifying α-amylase.
The reaction of glycosylation to hydroquinone with the enzyme was investigated in detail. Maltopentaose, maltotriose and soluble starch were effective substrates for glycoside formation, however, the efficiency of glycosylation with maltose was low. Hydroquinone could not be glucosylated by the enzyme with glucose. The enzyme was incubated in the reaction mixture containing 10 % of maltopentaose and 2 % of hydroquinone at 40 °C. In the initial part of the reaction, hydroquinone monoglucoside and hydroquinone oligoglucosides were detected. As the reaction continued, hydroquinone oligoglucosides were gradually decreased, while a hydroquinone monoglucoside was accumulated. 
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The structure of glucoside prepared with glucoamylase was elucidated. The structure of the glucoside was identified as 4-hydroxyphenyl-O-α-D-glucopyranoside, i.e., α-arbutin, on the basis of their isolation and subsequent analysis using α-and β-glucosidase treatment and 1 H-and 13 C-NMR analyses (Fig. 1) . The enzyme only catalyzed α-anomer selective transglycosylation toward hydroquinone, and from the reaction mixture, its anomer, i.e., arbutin was not detected at all. Several reports regarding chemical synthesis of α-arbutin were described (3, 4) . In those investigations, the reaction time was long, and the yields were low. Furthermore, chemical syntheses resulted in the production of a mixture of α-arbutin and arbutin. Recently, a highly stereo selective chemical synthesis of α-arbutin was reported (5) . However, arbutin was nevertheless produced as a byproduct accounting for nearly 20 % of the total products. There are several reports on enzymatic synthesis of α-arbutin with glucoside synthase (6) , sucrose phosphorylase (7) and α-glucosidase (8) . In those papers, molar conversion yield of α-arbutin synthesis by the sucrose phosphorylase and the α-glucosidase was very high (approximately 60 % and 90 %, respectively). However, the concentrations of hydroquinone of those reactions were approximately 1 %. The hydroquinone glucosylating enzyme could catalyze the glucosylating reaction toward hydroquinone effectively even if its concentration in the reaction mixture was much higher. The amount of α-arbutin produced with the enzyme reached more than 100 g/L. Several physicochemical properties of α-arbutin were similar to that of arbutin (9) except for their optical rotations ( Table I ). The browning resistance of α-arbutin, as well as arbutin, to light irradiation was for higher than that of hydroquinone (7) .
C. Glycosylation of Various Phenolic Compounds with Hydroquinone Glucosylating Enzyme
T h e a c c e p t o r s p e c i f i c i t y o f t h e h y d r o q u i n o n e glucosylating enzyme was examined (10) . The enzyme catalyzed the reaction of glycosylation to various phenolic compounds. In particular, hydroquinone, resorcinol, catechol, catechins and kojic acid were glycosylated with high efficiency. However, several alcoholic compounds were not glycosylated (Table II) . Comparison of glycosylation of dihydroxybenzenes and dimetoxyphenols indicated that the efficiency of glycosylation by the enzyme is decreased by the presence of groups close to the hydroxyl group to be glycosylated. Kojic acid is well known to have antimicrobial (11, 12) , chelating (12, 13) and tyrosinase inhibitory activities (14, 15) . The reaction of glycosylation to kojic acid was investigated in detail (10) . Kojic acid monoglucoside was accumulated at the end of the reaction. Analysis of the structure of kojic acid glucoside by 1 H-NMR and 13 C-NMR indicated that glucose was transferred to the hydroxymethyl group of kojic acid ( Fig. 2A ). In addition, maltol, the same -pyrone compound, and alcohols were not glycosylated by the enzyme. The structure of kojic acid might be significantly suitable for glycosylation with the enzyme. Comparing kojic acid and the kojic acid glucoside, the water solubility of the glucoside was approximately ten times higher than that of aglycone. In addition, the stability against ultraviolet light and bitter taste of kojic acid was improved by glycosylation.
One of the important factors for achieving the enzymatic glycosylation of phenolic compounds is to employ conditions in which a high concentration of acceptor molecule is dissolved in the reaction mixture. Caffeic acid is a typical hydroxycinnamic acid found in higher plants (16) . It is well recognized that caffeic acid has antioxidative activity (17, 18) and antimutagenic activity (19) . However, the solubility of caffeic acid in water is very poor, while it is soluble in alcohols. Because alcohols were not effective acceptor molecules for hydroquinone glucosylating enzyme, it was considered that the glycosylation of phenolic compound catalyzed by the enzyme was not inhibited competitively even in alcohols containing solutions. Thus, glycosylation of caffeic acid with the enzyme was examined in the reaction mixtures containing various concentrations of ethanol (20) . The glycosylation efficiencies were the greatest in the reaction mixtures containing 20 and 30 % ethanol. However, the amount of caffeic acid glucosides produced was the greatest in the reaction mixture containing 50 % ethanol, because the amount of soluble caffeic acid increased with increasing ethanol concentration. Caffeic acid monoglucosides was obtained from the reaction mixture, and they were identified to be caffeic acid 3-O-α-D-glucopyranoside (CAG-1) and caffeic acid 4-O-α-D-glucopyranoside (CAG-2) by 1 H-NMR and 13 C-NMR ( Fig. 2B, 2C ). The product that glucosylated both hydroxyl groups of caffeic acid was not detected. The solubility and browning resistance of caffeic acid was improved by glycosylation without loss of its antioxidative activity and antimutagenic activity. Especially, the solubilities of CAG-1 and CAG-2 were about 65-fold and 35-fold higher than that of caffeic acid, respectively. It is interesting to note that the solubility was greatly influenced by the binding position of glucose. The hydroquinone glucosylating enzyme possesses wide acceptor specificity for phenolic compounds and maintains the enzyme activity even in alcoholic solutions or at relative higher temperature. We consider that the hydroquinone glucosylating enzyme is a very useful enzyme for improving various phenolic compounds in nature.
D. Inhibitory Effect of α-Arbutin on Tyrosinases
One of the well-known skin-lightning agents for cosmetic products, arbutin, is a glycoside that hydroquinone is bound to glucose by β-glucosidic linkage. Efficacy of arbutin as a cosmetic ingredient has been studied in detail (21) (22) (23) (24) . As a result of glycosylation, cell toxicity of arbutin was a less than hydroquinone. The major mechanism of inhibitory effect of arbutin on melanin synthesis is thought to be inhibition of tyrosinase that is one of the key enzymes involved in melanin synthesis. Several researchers also investigated the inhibitory effect of α-arbutin on various tyrosinases (6, 7, 25) . The inhibitory activity of α-arbutin and arbutin against tyrosinases from mushroom and from B16 mouse melanoma cells was compared (Table III) (6) . They exhibited different specificity against these tyrosinases. α-Arbutin did not inhibit mushroom tyrosinase, while arbutin did. On the other hand, α-arbutin inhibited the tyrosinase from B16 mouse melanoma
-III cells more strongly than arbutin. We are very interested in the inhibitory effect of α-arbutin on human tyrosinase considering its application for cosmetics. We examined the inhibitory effects of α-arbutin and arbutin on the activity of tyrosinase from human malignant melanoma cells, HMV-II (provided by the Cell Resource Center for Biomedical Research, Tohoku University) (26, 27) . The cells were cultured for ten days in F12/DMEM supplemented with 10% fetal bovine serum and 100 µM L-DOPA at 37 °C in a humidified atmosphere of 5% CO 2 in air. Human tyrosinase was prepared by differential centrifugation of the cell homogenate. The inhibition of α-arbutin on human tyrosinase was stronger than that of arbutin. The 50% inhibitory concentration (IC 50 ) of α-arbutin was 2.0 mM, whereas that of arbutin was more 30 mM (Table III) . According to Lineweaver-Burk plots of the tyrosinase activity, the inhibition of α-arbutin against human tyrosinase was indicated to be competitive, and the Ki values for α-arbutin and arbutin were calculated as 0.2 mM and 4.2 mM, respectively. It is considered that the difference in the spectrum of tyrosinase inhibition between α-arbutin and arbutin is closely related to the structure of tyrosinase proteins. The amino acid sequence identity between human tyrosinase (28) and mushroom tyrosinase (Gene bank accession No., O42713) is only 23%. On the other hand, human tyrosinase and murine tyrosinase (29) are highly homologous (82% sequence identity). Since mushroom tyrosinase is commercially available, it might have been thought that the enzyme was useful for the first screening of a tyrosinase inhibitor. However, we considered that it is definitely important to use human tyrosinase for screening skin-lightening agents and that α-arbutin is a more effective skin-lightening agent than arbutin. 
E. Enzymatic Syntheses of α-Arbutin Glycosides and Arbutin Glycosides and Their Inhibitory Effects on Human Tyrosinase
We are interested in the effect of glycosyl residue of hydroquinone glycosides for the inhibitory effect on human tyrosinase, then we synthesized α-arbutin glycosides (30) and arbutin glycosides (27) and compared the inhibitory effect on human tyrosinase. These glycosides were obtained by transglycosylation reaction using cyclodextrin glycosyltransferase (CGTase) from Bacillus macerans. α-Arbutin or arbutin and soluble starch were used as the acceptor and the donor molecules, respectively. Both of α-arbutin and arbutin were good acceptor molecules because more than 70 % of α-arbutin and arbutin supplied was estimated to be glucosylated by HPLC analysis of the reaction mixture. Purification of the glycosides was performed by acetone extraction and subsequent separation using a column of Sephadex G-15, and we isolated two main compounds of each of α-arbutin glycosides and arbutin glycosides, respectively. The structural analyses using 13 C-NMR and 1 H-NMR proved that the transglycosylated products obtained from α-arbutin were 4-hydroxyphenyl α-maltoside (α-arbutinα-glucoside) and 4-hydroxyphenyl α-maltotrioside (α-arbutinα-maltoside), and the products obtained from arbutin were 4-hydroxyphenyl β-maltoside (arbutin-α-glucoside) and 4-hydroxyphenyl β-maltotrioside (arbutin-α-maltoside). We investigated the inhibitory effects of these compounds on human tyrosinase and compared with α-arbutin and arbutin (Table III) . These α-arbutin-α-glycosides and arbutin-αglycosides exhibited competitive type inhibition on human tyrosinase. The inhibitory activity of arbutin-α-glycosides was stronger than that of arbutin. On the other hand, the inhibitory activity of α-arbutin became lower by further glycosylation. To estimate the relationship between structure and inhibitory activity, we performed density functional theory (DFT) calculation. The structure optimizations of these inhibitors were performed using DFT program Dmol 3 , and electrostatic potential (ESP) was calculated on DFT-optimized structures. A comparison of optimized structures of these inhibitors indicated that α-arbutin-α-maltoside has a larger structural distortion than the others. The ESPs of these inhibitors revealed that a significant negative ESP existed in the region of π-clouds for the benzene ring of arbutin but not for those of the other inhibitors and L-tyrosine. These results indicate the possible existence of repulsive ESP for inhibiting the binding of arbutin in the substrate-binding site of human tyrosinase. We presume that the molecular size and ESP around the benzene ring are important in inducing the inhibitory effect of human tyrosinase inhibitors that contain a 4-hydroxyphenyl group.
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F. Inhibitory Effects of α-Arbutin on Melanin Synthesis in Human Melanoma Calls and in a Cultured Human Skin Model
To evaluate the efficacy of α-arbutin as a skinlightening agent, we examined the inhibitory effects of α-arbutin on melanin biosynthesis in cultured human melanoma cells and in a three-dimensional human skin model (31) . HMV-II human melanoma cells were cultured in F12/DMEM containing various concentrations of α-arbutin for 10 days. The cellular content of melanin was reduced by the addition of α-arbutin to the medium in a dose-dependent manner. Melanin synthesis was significantly inhibited at 0.5 mM, at which the melanin content was reduced to 76 % of that in non-treated cells. α-Arbutin did not inhibit cell viability at a concentration below 1.0 mM. These results indicate that α-arbutin had an inhibitory effect on melanogenesis at noncytotoxic concentrations ( 1 mM). We then examined the inhibitory action of α-arbutin on cellular tyrosinase activity in HMV-II cells. Treatment of the cells with α-arbutin reduced cellular tyrosinase activity in a dose-dependent manner. The tyrosinase activity was reduced to 60 % of that in the control at 0.5 mM, at which cell viability was not affected. To determine whether the expression of the tyrosinase gene was affected by α-arbutin, we measured mRNA levels by a semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) assay. The total cellular RNA was extracted from cells treated with 0.5 mM α-arbutin for 6 days. No significant difference was observed in tyrosinase gene expression between the α-arbutin-treated and non-treated HMV-II cells. Therefore, the inhibitory effects of α-arbutin on melanogenesis may be due to the direct inhibition of melanosomal tyrosinase activity, rather than the suppression of cell growth or tyrosinase gene expression.
To examine the effects of α-arbutin on natural skin pigmentation, we also evaluated the effect of α-arbutin on a human skin model (32, 33) , i.e., epidermal equivalents containing melanocytes and keratinocytes. Fig.3A shows the macroscopic darkening of the human skin model grown in the presence of different amounts of α-arbutin. Darkening of the model was clearly inhibited by the addition of 125 µg of α-arbutin. When the cultured tissue was observed under an inverted microscope, there were fewer darkened melanocytes in α-arbutin-treated tissue than in non-treated tissue (Fig. 3B) . To quantitatively evaluate the inhibitory effect of α-arbutin on cellular melanin synthesis, an acid-insoluble fraction was prepared from the tissues and the amount of melanin was measured. Melanin production of the human skin model was inhibited by α-arbutin in a dose dependent manner. When α-arbutin was applied at 125 and 250 µg/tissue for 13 days, the melanin production was reduced to 70 % and 40 % of 125µg 125µg 250µg 500µg that in non-treated cells, respectively. We also evaluated the cell viability in the human skin model that had been topically treated with different concentrations of α-arbutin by MTT assay. No significant decrease in cell viability was observed when the tissue was treated with up to 500 µg of α-arbutin. These results suggest that topical treatment of the tissue with α-arbutin decreased melanin synthesis without affecting cell viability. In this assay, most of the α-arbutin permeated the tissues, since 70 % of the total α-arbutin that was applied to the surface of tissue was recovered in the medium after incubation for 48 hours. Nevertheless, hydroquinone was not detected in the medium. These results suggest that the inhibitory effect of α-arbutin on melanin synthesis was not due to the action of hydroquinone released from α-arbutin. The inhibitory effects of hydroquinone on melanogenesis are considered to be due to the inhibition of tyrosinase in melanocytes and to melanocyte specific cytotoxicity (34) (35) (36) (37) . Glycosylation of hydroquinone results in a decrease of its cytotoxicity and in changing the mechanism of melanogenesis inhibition.
G. Conclusion
In this review, the glycosylation of several phenolic compounds with hydroquinone glucosylating enzyme and application studies of one of the glycosides, α-arbutin, for cosmetics were described. It was shown that water-solubility, stability and taste of these aglycones were improved by glycosylation. Furthermore, our studies suggest that glycosylation also affects the activities of bioactive compounds by changing their electrostatic nature. α-Arbutin was thought to be an effective and safe ingredient for skin-lightening. The effect of α-arbutin on preventing hyperpigmentation induced by UV-radiation in human skin was also confirmed (38) . We expect that our studies will contribute to raising the QOL.
H y d r o q u i n o n e g l u c o s y l a t i n g e n z y m e s h o w e d transglycosylating activity even in the reaction mixture containing a higher concentration of acceptor molecules or water miscible organic solvent. These abilities of this enzyme makes it possible to synthesize glycosides of various phenolic compound in high yield. In the future, the development of new functional glycosides as well as α-arbutin is expected to make further progress.
